| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |